In preclinical models of psoriasis, resolving D3 (RvD3) derived from ω-3 fatty acids prevented the development of both psoriasis-form itch and skin inflammation with the concomitant decreased expression of CGRP in TRPV1+ neurons (Lee et al., 2020). The gene discussed is TRPV1; the disease is dermatitis.